Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
SciClone Pharmaceuticals · Hepatitis C · Hepatitis C, Chronic
Phase 3
Completed
500
2008-01
Industry sponsor intelligence
SciClone PharmaceuticalsClinical Pipeline.
Lead-sponsor view of SciClone Pharmaceuticals's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 5
- Recruiting
- 0
- Active
- 0
- Completed
- 3
- Results posted
- 0
- Avg enrollment
- 332
Pipeline overview
Programs by phase and activity.
Velocity
SciClone Pharmaceuticals trials by start year
Study start year · indexed snapshot
Development
Trials by phase
6phase labels
Early Phase 10
Phase 11
Phase 23
Phase 32
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Thymosin Alpha-1 → | 5 | 1 | 3 | 2 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
SciClone Pharmaceuticals · Hepatitis C · Hepatitis C, Chronic
Phase 3
Completed
500
2008-01
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
SciClone Pharmaceuticals · Carcinoma, Hepatocellular
Phase 2
Completed
—
2008-01
Search sponsor records
All SciClone Pharmaceuticals studies.
This page groups studies where SciClone Pharmaceuticals is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
5 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT02906150Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild TypeSep 19, 2016NCT02906163First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care TherapySep 19, 2016NCT00039962Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus RibavirinJan 15, 2008NCT00040027Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinJan 15, 2008NCT00082082A Trial of Thymalfasin in Adult Patients With Hepatocellular CarcinomaJan 15, 2008